Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kelsey A Klute"'
Autor:
Jeffrey M. Ryckman, Bradley N. Reames, Kelsey A. Klute, William A. Hall, Michael J. Baine, May Abdel-Wahab, Chi Lin
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 28, Iss , Pp 124-128 (2021)
Stereotactic Radiotherapy (SRT) over 5-15 days can be interdigitated without delaying chemotherapy. Bridging chemotherapy may allow for extended intervals to surgery, potentially improving sterilization of surgical margins and overall survival. SRT f
Externí odkaz:
https://doaj.org/article/d8bf5383a44a49a6a63bfaa9e2ca55f6
Autor:
Rudolph Navari, Gary Binder, Alex Molasiotis, Jørn Herrstedt, Eric J Roeland, Kathryn J Ruddy, Thomas W LeBlanc, Dwight D Kloth, Kelsey A Klute, Eros Papademetriou, Luke Schmerold, Lee Schwartzberg
Publikováno v:
The Oncologist. 28:208-213
Background The relationship between CINV duration and recurrence in subsequent cycles is largely unstudied. Our objective was to determine if patients experiencing CINV in their first cycle of chemotherapy (C1) would face increased risk of CINV in la
Autor:
Gang Wang, Jianlong Li, Linda Bojmar, Haiyan Chen, Zhong Li, Gabriel C. Tobias, Mengying Hu, Edwin A. Homan, Serena Lucotti, Fengbo Zhao, Valentina Posada, Peter R. Oxley, Michele Cioffi, Han Sang Kim, Huajuan Wang, Pernille Lauritzen, Nancy Boudreau, Zhanjun Shi, Christin E. Burd, Jonathan H. Zippin, James C. Lo, Geoffrey S. Pitt, Jonathan Hernandez, Constantinos P. Zambirinis, Michael A. Hollingsworth, Paul M. Grandgenett, Maneesh Jain, Surinder K. Batra, Dominick J. DiMaio, Jean L. Grem, Kelsey A. Klute, Tanya M. Trippett, Mikala Egeblad, Doru Paul, Jacqueline Bromberg, David Kelsen, Vinagolu K. Rajasekhar, John H. Healey, Irina R. Matei, William R. Jarnagin, Robert E. Schwartz, Haiying Zhang, David Lyden
Publikováno v:
Nature.
Autor:
Krysten Vance, Alphan Alitinok, Seth Winfree, Heather Jensen-Smith, Benjamin J. Swanson, Paul M. Grandgenett, Kelsey A. Klute, Daniel J. Crichton, Michael A. Hollingsworth
Publikováno v:
Cancer Biomarkers. 33:219-235
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a formidable challenge for patients and clinicians. OBJECTIVE: To analyze the distribution of 31 different markers in tumor and stromal portions of the tumor microenvironment (TME) and identify i
Autor:
Gloria F. Gerber MD, Kelsey A. Klute MD, John Chapin MD, James Bussel MD, Maria T. DeSancho MD, MSc
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Factor XI (FXI) deficiency is an uncommon autosomal disorder with variable bleeding phenotype, making peripartum management challenging. We describe our experience in pregnant women with FXI deficiency and identify strategies to minimize the use of h
Externí odkaz:
https://doaj.org/article/a24037a0d8f54c8e861b320b899f299d
Autor:
Kelsey A, Klute, Michael, Rothe, Elizabeth, Garrett-Mayer, Pam K, Mangat, Reza, Nazemzadeh, Kathleen J, Yost, Herbert L, Duvivier, Eugene R, Ahn, Timothy L, Cannon, Olatunji B, Alese, John C, Krauss, Ramya, Thota, Carmen J, Calfa, Crystal S, Denlinger, Raegan, O'Lone, Susan, Halabi, Gina N, Grantham, Richard L, Schilsky
Publikováno v:
JCO precision oncology. 6
TAPUR is a phase II basket trial evaluating the antitumor activity of commercially available targeted agents in patients with advanced cancer and genomic alterations known to be drug targets. The results of a cohort of patients with colorectal cancer
Autor:
Krysten Vance, Alphan Alitinok, Seth Winfree, Heather Jensen-Smith, Benjamin J. Swanson, Paul M. Grandgenett, Kelsey A. Klute, Daniel J. Crichton, Michael A. Hollingsworth
Publikováno v:
Cancer Biomark
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a formidable challenge for patients and clinicians. OBJECTIVE: To analyze the distribution of 31 different markers in tumor and stromal portions of the tumor microenvironment (TME) and identify i
Autor:
Dan He, Huijin Feng, Belen Sundberg, Jiaxing Yang, Justin Powers, Alec H. Christian, John E. Wilkinson, Cian Monnin, Daina Avizonis, Craig J. Thomas, Richard A. Friedman, Michael D. Kluger, Michael A. Hollingsworth, Paul M. Grandgenett, Kelsey A. Klute, F. Dean Toste, Christopher J. Chang, Iok In Christine Chio
Publikováno v:
Molecular Cell. 82:3045-3060.e11
Cancer mortality is primarily a consequence of its metastatic spread. Here, we report that methionine sulfoxide reductase A (MSRA), which can reduce oxidized methionine residues, acts as a suppressor of pancreatic ductal adenocarcinoma (PDA) metastas
Autor:
Manish A. Shah, Rhonda K. Yantiss, Daoqi You, Elizabeta C. Popa, Michael D. Lieberman, Nasser K. Altorki, Allyson J. Ocean, Joseph M. Scandura, Andrew M. Schreiner, Kelsey A. Klute, Romae Palmer, Paul J. Christos, Agnes Viale, Bryan J. Schneider, Pouneh Kermani
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 23(11)
Purpose: Epigenetic silencing of tumor suppressor genes (TSG) is an acquired abnormality observed in cancer and is prototypically linked to DNA methylation. We postulated that pretreatment (priming) with 5-azacitidine would increase the efficacy of c
Publikováno v:
Journal of thrombosis and thrombolysis. 42(2)
Splanchnic vein thrombosis (SVT) is an uncommon form of venous thrombosis. Management can be challenging due to underlying conditions, increased bleeding risk, and lack of evidence from clinical trials. We sought to characterize the presentation and